OPIANT PHARMACEUTICALS, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Opiant Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2022.
  • Opiant Pharmaceuticals, Inc. Debt-to-equity for the quarter ending September 30, 2022 was 62.6 %, a 9.57% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 62.6 -6.63 -9.57% Sep 30, 2022
Q2 2022 57.6 -0.5 -0.86% Jun 30, 2022
Q1 2022 59 +14.6 +32.8% Mar 31, 2022
Q4 2021 63.4 +33.6 +113% Dec 31, 2021
Q3 2021 69.3 +53.2 +332% Sep 30, 2021
Q2 2021 58.1 +39.3 +209% Jun 30, 2021
Q1 2021 44.4 +20.4 +84.6% Mar 31, 2021
Q4 2020 29.8 -3.14 -9.54% Dec 31, 2020
Q3 2020 16.1 -31.4 -66.2% Sep 30, 2020
Q2 2020 18.8 -25.4 -57.5% Jun 30, 2020
Q1 2020 24.1 -24.4 -50.3% Mar 31, 2020
Q4 2019 32.9 -21.9 -40% Dec 31, 2019
Q3 2019 47.5 -2.31 -4.64% Sep 30, 2019
Q2 2019 44.2 -60.9 -57.9% Jun 30, 2019
Q1 2019 48.4 -75.2 -60.8% Mar 31, 2019
Q4 2018 54.8 -67.5 -55.2% Dec 31, 2018
Q3 2018 49.8 -127 -71.8% Sep 30, 2018
Q2 2018 105 -171 -62% Jun 30, 2018
Q1 2018 124 -6.28K -98.1% Mar 31, 2018
Q4 2017 122 +477 Dec 31, 2017
Q3 2017 176 +318 Oct 31, 2017
Q2 2017 277 +404 Jul 31, 2017
Q1 2017 6.4K +6.52K Apr 30, 2017
Q4 2016 -355 -242 -215% Jan 31, 2017
Q3 2016 -141 -30 -26.9% Oct 31, 2016
Q2 2016 -127 -8.39 -7.05% Jul 31, 2016
Q1 2016 -118 +4.96 +4.03% Apr 30, 2016
Q4 2015 -113 +9.78 +7.99% Jan 31, 2016
Q3 2015 -112 +13.8 +11% Oct 31, 2015
Q2 2015 -119 -3.74 -3.25% Jul 31, 2015
Q1 2015 -123 +1.8 +1.44% Apr 30, 2015
Q4 2014 -122 +19.3 +13.6% Jan 31, 2015
Q3 2014 -125 +16.7 +11.8% Oct 31, 2014
Q2 2014 -115 +29.4 +20.3% Jul 31, 2014
Q1 2014 -125 +5.28 +4.06% Apr 30, 2014
Q4 2013 -142 -31.8 -28.9% Jan 31, 2014
Q3 2013 -142 -33.3 -30.6% Oct 31, 2013
Q2 2013 -145 -31.9 -28.3% Jul 31, 2013
Q1 2013 -130 -12.5 -10.6% Apr 30, 2013
Q4 2012 -110 Jan 31, 2013
Q3 2012 -109 Oct 31, 2012
Q2 2012 -113 Jul 31, 2012
Q1 2012 -118 Apr 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.